How the FDA Views Compounding

Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), talks about the current position of the FDA regarding compounding.

Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), talks about the current position of the FDA regarding compounding.

This video was recorded at the 2015 NCPA Annual Convention.

Related Content:

Interviews503B Compounding PharmacyRetail
Experts Express Concern About Lower Rates of Flu, Pneumococcal Vaccination Rates
Study Links New Type 1 Diabetes Diagnoses, Prior COVID-19 in Pediatric Patients
Boosting Immunization Efforts Can Fill in Coverage Gaps, Improve Pharmacies’ Financial Health